Katrina Abuabara, MD

Incidence of Cardiovascular Disease and Venous Thromboembolism in Patients With Atopic Dermatitis.

Wan J, Fuxench ZCC, Wang S, Syed MN, Shin DB, Abuabara K, Lemeshow AR, Gelfand JM PMID: 37572754

Malignancy risk in patients with atopic dermatitis: a population-based cohort study.

Wan J, Shin DB, Syed MN, Abuabara K, Lemeshow AR, Fuxench ZCC, Gelfand JM PMID: 37418646

Sodium in the skin: a summary of the physiology and a scoping review of disease associations.

Chattopadhyay A, Tully J, Shan J, Sheikh S, Ohliger M, Gordon JW, Mauro T, Abuabara K PMID: 36970766

Air pollution and global healthcare use for atopic dermatitis: A systematic review.

Fadadu RP, Chee E, Jung A, Chen JY, Abuabara K, Wei ML PMID: 37184289

Atopic dermatitis across the life course.

Abuabara K, Langan SM PMID: 36715326

Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.

Silverberg JI, Lynde CW, Abuabara K, Patruno C, de Benedetto A, Zhang H, Thomas RB, Bégo-Le-Bagousse G, Khokhar FA, Vakil J, Marco AR, Levit NA PMID: 37193879

Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort.

Silverberg JI, Simpson B, Abuabara K, Guttman-Yassky E, Calimlim B, Wegzyn C, Krueger W, Gamelli A, Munoz B, Faller RW, Crawford JM, Grada A, Eichenfield LF, TARGET-DERM Investigators PMID: 37150299

Distribution of Early Career Research Funding by Specialty from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Chiang BM, Gelfand JM, Margolis DJ, Abuabara K PMID: 37076209

Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry.

Guttman-Yassky E, Bar J, Rothenberg-Lausell C, Eichenfield L, Grada A, Abuabara K, Chapman M, Calimlim B, Wegzyn C, Gamelli A, Krueger W, Munoz B, Knapp K, Faller R, Crawford J, Silverberg J PMID: 37026893

Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.

Silverberg JI, Lynde CW, Abuabara K, Patruno C, de Benedetto A, Zhang H, Thomas RB, Bégo-Le-Bagousse G, Khokhar FA, Vakil J, Marco AR, Levit NA PMID: 36808602